Organization: Industrial Research Assistance Program

Busy committee members report in person

The Canada Research Coordinating Committee continues to focus on leading challenges in R&D and innovation. One of those challenges — a lack of live venues for talking about them — was finally overcome at this year’s Canadian Science Policy Conference.

Marking a Eureka moment

Canada is now a full member of the Eureka network, an international R&D consortium that includes more than 40 countries on five continents. Over the past decade some 300 Canadians have participated in Eureka projects, which have been worth more than $500 million.

The Short Report – August 26, 2020: Ottawa wants a data-driven approach to housing, federally backed Newfoundland startup launches prototype, and more

The St. John’s, Newfoundland-based tech startup Avalon Holographics launched its first-generation prototype display; the federal government will launch the first round of its $300-million Housing Supply Challenge, focused on the provision of reliable housing data; Alberta Premier Jason Kenney put Doug Schweitzer at the head of his new ministry of Jobs, Economy and Innovation; and more.

Canada’s next industrial strategy needs to focus on business innovation

By Bert van den Berg The New North Star II report should be lauded for suggesting the creation of a national, challenge-driven industrial strategy.  As others have noted, such a strategy would represent an important change for Canada. Past decades have seen a laissez-faire approach focused on ensuring favourable business conditions … an approach that…

The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more

Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…